RU2015134772A3 - - Google Patents

Download PDF

Info

Publication number: RU2015134772A3
Authority: RU; Russia

Application number

RU2015134772A

Other languages

Russian (ru)

Other versions

RU2015134772A (en

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-13

Publication date

2018-03-21

2014-03-13 Application filed filed Critical

2017-04-21 Publication of RU2015134772A publication Critical patent/RU2015134772A/en

2018-03-21 Publication of RU2015134772A3 publication Critical patent/RU2015134772A3/ru

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

RU2015134772A 2013-03-15 2014-03-13 APPLICATION OF BIMATOPROST TO INCREASE THE PRODUCTION OF LEPTIN RU2015134772A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361793132P	2013-03-15	2013-03-15
US61/793,132		2013-03-15
PCT/US2014/026110 WO2014143629A1 (en)	2013-03-15	2014-03-13	Bimatoprost for enhancement of leptin production

Publications (2)

Publication Number	Publication Date
RU2015134772A RU2015134772A (en)	2017-04-21
RU2015134772A3 true RU2015134772A3 (en)	2018-03-21

Family

ID=50442712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2015134772A RU2015134772A (en)	2013-03-15	2014-03-13	APPLICATION OF BIMATOPROST TO INCREASE THE PRODUCTION OF LEPTIN

Country Status (11)

Country	Link
US (2)	US20140275272A1 (en)
EP (1)	EP2968361A1 (en)
JP (1)	JP2016513647A (en)
KR (1)	KR20150129735A (en)
CN (1)	CN105338985A (en)
AU (1)	AU2014228307A1 (en)
BR (1)	BR112015021859A2 (en)
CA (1)	CA2901529A1 (en)
HK (1)	HK1220385A1 (en)
RU (1)	RU2015134772A (en)
WO (1)	WO2014143629A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA120775C2 (en)	2015-04-30	2020-02-10	Аллерган, Інк.	COSMETIC METHOD AND ITS THERAPEUTIC APPLICATION TO REDUCE ADDITIVE TISSUE VOLUME

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4911920A (en)	1986-07-30	1990-03-27	Alcon Laboratories, Inc.	Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (en)	1985-10-03	1988-12-02	Merck Sharp & Dohme	LIQUID-GEL PHASE TRANSITION PHARMACEUTICAL COMPOSITION
JP2594486B2 (en)	1991-01-15	1997-03-26	アルコンラボラトリーズインコーポレイテッド	Topical ophthalmic composition
US5212162A (en)	1991-03-27	1993-05-18	Alcon Laboratories, Inc.	Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5688819A (en)	1992-09-21	1997-11-18	Allergan	Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
CA2681668C (en) *	2006-03-23	2014-04-01	Michael S. Singer	Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
CA2749352A1 (en) *	2009-02-20	2010-09-10	Micro Labs Limited	Storage stable prostaglandin product
EP2982373B1 (en) *	2011-01-19	2018-06-13	Topokine Therapeutics, Inc.	Methods and compostions for reducing body fat

2014
- 2014-03-13 CA CA2901529A patent/CA2901529A1/en not_active Abandoned
- 2014-03-13 HK HK16108521.3A patent/HK1220385A1/en unknown
- 2014-03-13 KR KR1020157025059A patent/KR20150129735A/en not_active Withdrawn
- 2014-03-13 AU AU2014228307A patent/AU2014228307A1/en not_active Abandoned
- 2014-03-13 BR BR112015021859A patent/BR112015021859A2/en active Search and Examination
- 2014-03-13 EP EP14716168.1A patent/EP2968361A1/en not_active Withdrawn
- 2014-03-13 JP JP2016502054A patent/JP2016513647A/en active Pending
- 2014-03-13 US US14/209,099 patent/US20140275272A1/en not_active Abandoned
- 2014-03-13 WO PCT/US2014/026110 patent/WO2014143629A1/en not_active Ceased
- 2014-03-13 RU RU2015134772A patent/RU2015134772A/en not_active Application Discontinuation
- 2014-03-13 CN CN201480012846.5A patent/CN105338985A/en active Pending
2015
- 2015-11-25 US US14/952,208 patent/US20160310505A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20140275272A1 (en)	2014-09-18
CN105338985A (en)	2016-02-17
BR112015021859A2 (en)	2017-07-18
HK1220385A1 (en)	2017-05-05
JP2016513647A (en)	2016-05-16
KR20150129735A (en)	2015-11-20
AU2014228307A1 (en)	2015-09-10
EP2968361A1 (en)	2016-01-20
CA2901529A1 (en)	2014-09-18
RU2015134772A (en)	2017-04-21
US20160310505A1 (en)	2016-10-27
WO2014143629A1 (en)	2014-09-18

Publication	Publication Date	Title
AP2016009275A0 (en)	2016-06-30
BR102016010778A2 (en)	2017-08-08
BR112014017733A2 (en)	2017-06-20
BR112014018502A2 (en)	2017-06-20
BR112014017739A2 (en)	2017-06-20
BR112014019326A2 (en)	2017-06-20
BR112014018480A2 (en)	2017-06-20
BR112014018516A2 (en)	2017-06-20
BR112016011479A2 (en)	2017-08-08
BR112014020341A2 (en)	2017-06-20
BR112014017855A2 (en)	2017-06-20
BR112014017765A2 (en)	2017-06-20
BR112014017669A2 (en)	2017-06-20
BR112014021878A2 (en)	2017-06-20
BR112014018468A2 (en)	2017-06-20
BR112014017901A2 (en)	2017-06-20
BR112014019204A2 (en)	2017-06-20
BR112014018207A2 (en)	2017-06-20
BR112015015948A2 (en)	2017-08-15
BR112014017722A2 (en)	2017-06-20
BR112014017653A2 (en)	2017-06-20
BR112014018578A2 (en)	2017-06-20
BR112014018483A2 (en)	2017-06-20
BR112014017794A2 (en)	2017-06-20
BR112014017601A2 (en)	2017-06-20

Legal Events

Date	Code	Title	Description
2018-08-10	FA92	Acknowledgement of application withdrawn (lack of supplementary materials submitted)	Effective date: 20180731